Scarica l'app Stockscreener
8.88
1.00%
-0.09
Dopo l'orario di chiusura:
8.88
Precedente Chiudi:
$8.97
Aprire:
$8.95
Volume 24 ore:
133.25K
Relative Volume:
0.43
Capitalizzazione di mercato:
$293.76M
Reddito:
$65.42M
Utile/perdita netta:
$-32.96M
Rapporto P/E:
-6.9921
EPS:
-1.27
Flusso di cassa netto:
$-19.87M
1 W Prestazione:
+2.54%
1M Prestazione:
-1.11%
6M Prestazione:
-29.30%
1 anno Prestazione:
+13.55%
Intervallo 1D:
$8.76
$8.98
Intervallo di 1 settimana:
$8.415
$9.17
Portata 52W:
$5.45
$18.98
Neuropace Inc Stock (NPCE) Company Profile
Nome
Neuropace Inc
Settore
Industria
Telefono
(650) 237-2700
Indirizzo
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Confronta NPCE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
8.88 | 296.74M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
131.46 | 229.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.87 | 157.64B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
393.15 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.05 | 118.26B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.90 | 47.71B | 5.69B | 1.41B | 577.90M | 6.95 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-21 | Iniziato | UBS | Buy |
| 2024-03-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Iniziato | Leerink Partners | Outperform |
| 2023-11-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-08-24 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | Iniziato | Lake Street | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-01-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | Iniziato | Robert W. Baird | Outperform |
| 2021-05-17 | Iniziato | JP Morgan | Overweight |
| 2021-05-17 | Iniziato | Morgan Stanley | Overweight |
| 2021-05-17 | Iniziato | SVB Leerink | Outperform |
| 2021-05-17 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Neuropace Inc Borsa (NPCE) Ultime notizie
Relative strength of NeuroPace Inc. in sector analysisQuarterly Growth Report & Daily Entry Point Alerts - Newser
Published on: 2025-08-27 07:52:16 - Newser
NeuroPace Inc. stock daily chart insights2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Applying chart zones and confluence areas to NeuroPace Inc.July 2025 Trends & Growth Oriented Trade Recommendations - Newser
Is NeuroPace Inc. stock reversal real or fake2025 Analyst Calls & Reliable Volume Spike Alerts - Newser
Should you hold or exit NeuroPace Inc. now2025 Fundamental Recap & AI Driven Stock Reports - Newser
NeuroPace Inc. Tests 50 Day MA After Sharp Decline getLinesFromResByArray error: size == 0 - 더경남뉴스
NeuroPace Inc. stock retracement – recovery analysisWeekly Trade Recap & Verified Technical Trade Signals - Newser
Can NeuroPace Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - kangso.co.kr
Applying sector rotation models to NeuroPace Inc.Market Movement Recap & Smart Investment Allocation Tips - Newser
Will NeuroPace Inc. stock recover after earningsRate Cut & Weekly Sector Rotation Insights - sundaytimes.kr
How hedge fund analytics apply to NeuroPace Inc. stock2025 Market Overview & Technical Pattern Based Signals - Newser
Using Bollinger Bands to evaluate NeuroPace Inc.2025 Technical Patterns & Risk Managed Investment Signals - Newser
Moving Average Crossover Confirms Uptrend in NeuroPace Inc.Exit Point & Growth-Oriented Investment Plans - beatles.ru
When is the best time to exit NeuroPace Inc.Trade Signal Summary & Weekly High Return Stock Forecasts - Newser
NeuroPace, Inc. (NASDAQ:NPCE) Receives $16.60 Consensus Target Price from Analysts - MarketBeat
Is a relief rally coming for NeuroPace Inc. holdersEntry Point & Verified Technical Trade Signals - Newser
Trading Action: Can NeuroPace Inc. sustain earnings growthJuly 2025 News Drivers & Fast Gain Stock Tips - theviewers.co.kr
What is HC Wainwright's Estimate for NeuroPace Q3 Earnings? - MarketBeat
NeuroPace Inc. Hits Oversold Level on RSI IndicatorWatch List & Stock Timing and Entry Methods - classian.co.kr
Neuropace (NPCE) Stock: A Bearish Crossroads of Technical and Fundamental Risks - AInvest
Leerink Partnrs Boosts Earnings Estimates for NeuroPace - MarketBeat
FY2029 EPS Estimates for NeuroPace Raised by Leerink Partnrs - MarketBeat
What is HC Wainwright's Forecast for NeuroPace Q1 Earnings? - MarketBeat
Lord Abbett & CO. LLC Takes Position in NeuroPace, Inc. $NPCE - MarketBeat
What risks could impact NeuroPace Inc. stock performanceWall Street Watch & Verified Momentum Stock Watchlist - Newser
Wells Fargo & Company Lowers NeuroPace (NASDAQ:NPCE) Price Target to $15.00 - MarketBeat
Deutsche Bank AG Has $11.36 Million Holdings in NeuroPace, Inc. $NPCE - MarketBeat
AI Trend Models Suggest Bounce for NeuroPace Inc.July 2025 Weekly Recap & High Accuracy Buy Signal Tips - newsimpact.co.kr
Q3 Earnings Estimate for NeuroPace Issued By HC Wainwright - Defense World
NeuroPace (NASDAQ:NPCE) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Will NeuroPace Inc. bounce back from current supportJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Is NeuroPace Inc. stock ready for a breakoutTrade Risk Assessment & Low Volatility Stock Recommendations - Newser
Price momentum metrics for NeuroPace Inc. explainedMarket Movement Recap & Expert Approved Momentum Ideas - Newser
NeuroPace FY2025 EPS Estimate Boosted by Cantor Fitzgerald - MarketBeat
Why NeuroPace Inc. stock attracts strong analyst attentionPortfolio Performance Summary & Fast Moving Stock Trade Plans - Newser
Cantor Fitzgerald Boosts Earnings Estimates for NeuroPace - Defense World
What is HC Wainwright’s Forecast for NeuroPace Q1 Earnings? - Defense World
FY2025 EPS Estimates for NeuroPace Lifted by Leerink Partnrs - Defense World
Neuropace’s Innovative Approach to Treating Lennox-Gastaut Syndrome - MSN
Reversal indicators forming on NeuroPace Inc. stockJuly 2025 Breakouts & Safe Capital Growth Tips - Newser
Is NeuroPace Inc. in a long term uptrend2025 AllTime Highs & High Accuracy Swing Entry Alerts - thegnnews.com
Neuropace Inc Azioni (NPCE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.76%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):